Skip to main content

Shopping Cart

You're getting the VIP treatment!

Item(s) unavailable for purchase
Please review your cart. You can remove the unavailable item(s) now or we'll automatically remove it at Checkout.
itemsitem
itemsitem

Recommended For You

Loading...


“deborah rosenbaum”

Showing 1 - 12 of 12 results for “deborah rosenbaum”
Skip side bar filters
  • Physician Investigator Handbook

    GCP Tools and Techniques, Second Edition

    A comprehensive guide for physicians conducting clinical research, this second edition addresses a broader research perspective. It includes information on the implications of the ICH Guidelines, current FDA regulations, and an Internet address directory. Everything the clinical trial manager, planner, monitor, and investigator need to know about t ... Read more

    $94.99 USD

People who read this also enjoyed

  • Clinical Research Coordinator Handbook, Fourth Edition

    In this fully revised and expanded fourth edition of the essential reference for clinical research coordinators, Deborrah Norris provides expanded coverage of CRC duties and regulatory requirements, including new sections on investigator responsibilities, data clarification, and adverse event reporting. The books five appendices include a directory of CRC resources, updated forms and checklists, ... Read more

    $9.99 USD or Free with Kobo Plus

  • Clinical Research Coordinator Handbook, 5th edition

    “This extremely useful title is written for anyone planning to implement clinical trials at an institution. … the author has carefully detailed the types of forms, study records, and case report forms. … A powerful appendix and glossary of relevant terms help make this a needed book for any clinical trials office.”— Journal of Hospital LibrarianshipIn this fully revised and expanded fifth edition ... Read more

    $9.99 USD or Free with Kobo Plus

  • Clinical Trials Audit Preparation

    A Guide for Good Clinical Practice (GCP) Inspections

    A must-have guide for any professional in the drug manufacturing industryThe Good Clinical Practice (GCP) audit is a tedious but necessary exercise that assures that all parties do their job properly and in compliance with the applicable FDA code. Clinical Trials Audit Preparation demystifies the audit process for all parties involved, including clinical research sponsors, clinical investigators, ... Read more

    $97.00 USD

  • Principles and Practice of Clinical Research

    The third edition of this innovative work again provides a unique perspective on the clinical discovery process by providing input from experts within the NIH on the principles and practice of clinical research. Molecular medicine, genomics, and proteomics have opened vast opportunities for translation of basic science observations to the bedside through clinical research. As an introductory ... Read more

    $112.49 USD

  • Drug Information: A Guide for Pharmacists, Seventh Edition

    Everything pharmacists and pharmacy students need to know about drug information managementA Doody's Core Title for 2023, 2024 & 2026!Drug Information: A Guide for Pharmacists provides you with the tools you need to to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible. This trusted resource addresses essential topics such ... Read more

    $93.59 USD

  • Drug Information: A Guide for Pharmacists, Sixth Edition

    The guide pharmacists and students turn to first for cutting-edge coverage of drug informationA Doody’s Core Title for 2021!The goal of Drug Information: A Guide for Pharmacists, Sixth Edition is to teach students and practitioners how to effectively research, interpret, evaluate, collate, and disseminate drug information in the most efficient and effective manner possible. Updated to reflect the ... Read more

    $85.49 USD

  • Early Drug Development

    Strategies and Routes to First-in-Human Trials

    Edited by Mitchell N. Cayen ...
    The focus of early drug development has been the submission of an Investigational New Drug application to regulatory agencies. Early Drug Development: Strategies and Routes to First-in-Human Trials guides drug development organizations in preparing and submitting an Investigational New Drug (IND) application. By explaining the nuts and bolts of preclinical development activities and their ... Read more

    $161.00 USD

  • Textbook of Pharmacoepidemiology

    Textbook of Pharmacoepidemiology, Second Edition, provides an introduction to pharmacoepidemiology and the data sources, methods and applications used in clinical research, the pharmaceutical industryand regulatory agencies.Drawing upon the fifth edition of the authoritative reference, Pharmacoepidemiology, this new edition covers the key learning requirements of the discipline. The textbook ... Read more

    $96.95 USD

  • A Clinical Trials Manual From The Duke Clinical Research Institute

    Lessons from a Horse Named Jim

    "The publication of the second edition of this manual comes at an important juncture in the history of clinical research. As advances in information technology make it possible to link individuals and groups in diverse locations in jointly seeking the answers to pressing global health problems, it is critically important to remain vigilant about moral and ethical safeguards for every patient ... Read more

    $80.00 USD

  • Real-World Evidence in Drug Development and Evaluation

    Edited by Harry Yang, Binbing Yu ...
    Series series Chapman & Hall/CRC Biostatistics Series
    Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering ... Read more

    Was $57.99 USD Now $51.99 USD

  • Fast Facts: Biosimilars in Hematology and Oncology

    Biologics and biosimilars - getting decisions right

    Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – ... Read more

    Free